Table 2

Effect of various amphipathic compounds on [3H]5-HT binding, cAMP production, and GTPγ35S Binding at human 5-HT7Areceptors expressed in HEK293 cells

[3H]5-HT BindingcAMP ProductionGTPγ35S Binding of 5-HT
KDBmaxEC50Emax
nM pmol/mg protein nM pmol/well %
Control1.5  ± 0.11.7  ± 0.28.1  ± 0.79.1  ± 0.1100
CHAPS2-a 1.4  ± 0.12.6  ± 0.12-150 3.7  ± 0.42-160 8.4  ± 0.3133  ± 7
Oleic acid, 15 μM1.3  ± 0.22.2  ± 0.22-150 4.0  ± 0.42-160 9.0  ± 0.5137  ± 5
FF-BSA, 3%1.2  ± 0.21.1  ± 0.12-150 13.9  ± 1.22-160 9.1  ± 0.856  ± 4
LPC (50 μM)1.4  ± 0.11.2  ± 0.22-150 15.8  ± 1.62-160 8.3  ± 0.355  ± 10

Cellular cAMP changes were monitored using a FlashPlate assay kit from PerkinElmer in HEK 293 cells in a 96-well plate. A standard curve with various concentrations of cAMP was constructed, following the vendor's protocol. The basal levels of cAMP were less than 0.2 pmol/well and were not appreciably affected by addition of the listed compounds. The 5-HT–induced GTPγ35S binding was measured in isolated HEK 293 cell membranes in the presence or absence of 10 μM 5-HT and 2 nM GTPγ35S. Methiothepin at 100 μM blocked 5-HT–induced GTPγ35S binding and by itself showed no effect. The data represent the mean ± S.E.M. (n = 3).

    • 2-a  0.2% for [3H]5-HT Binding, but 0.1% for cAMP and GTPγ35S binding.

    • 2-150 , p < 0.01 from t test

    • 2-160 , p < 0.05 from t test